Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth C. Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil S. Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Maccon M. KeaneHenry L. Gomez Moreno, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam M. Brufsky, Deborah L. Toppmeyer, Virginia G. Kaklamani, Jeffrey L. Berenberg, Jeffrey Abrams, George W. Sledge

Research output: Contribution to journal › Article › peer-review

332 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences